ZR2 Bioenergy Ltd Fair Value
ZR2 · Chemicals · Current price ₹114.55
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹75 | 0% ROE fading to 13% over ~3 yrs, on ₹89 book |
| Relative P/E | ₹38 | EPS × 47.8 peer-median P/E |
| Graham floor | ₹40 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is ZR2 Bioenergy Ltd undervalued?
DocStoX estimates the fair value of ZR2 Bioenergy Ltd at ₹57 per share, versus the current market price of ₹115. That puts the stock about -49.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹75), Relative P/E (₹38), Graham floor (₹40). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹38 (bear) to ₹57 (base) to ₹75 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on ZR2 Bioenergy Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.